Atracurium Besylate (Sagent Pharmaceuticals)
Welcome to the PulseAid listing for the Atracurium Besylate drug offered from Sagent Pharmaceuticals. This Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sagent Pharmaceuticals |
| NON-PROPRIETARY NAME: | atracurium besylate |
| SUBSTANCE NAME: | ATRACURIUM BESYLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-07-31 |
| END MARKETING DATE: | 0000-00-00 |
Atracurium Besylate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Atracurium Besylate from Sagent Pharmaceuticals |
| LABELER NAME: | Sagent Pharmaceuticals |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/mL) |
| START MARKETING DATE: | 2015-07-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 25021-659_2499d6bc-6ece-44f3-b8d7-f68b6d705fd8 |
| PRODUCT NDC: | 25021-659 |
| APPLICATION NUMBER: | ANDA091488 |
Other ATRACURIUM BESYLATE Pharmaceutical Manufacturers / Labelers:
